Silvergleid A J
JAMA. 1979 Jun 22;241(25):2724-5. doi: 10.1001/jama.241.25.2724.
Review of the clinical records of 103 patients participating in a community-blood-bank-sponsored autologous transfusion program confirmed the safety of autologous blood and the practically of such a community-centered program. There were no transfusion reactions, increased morbidity, or reports of hepatitis among the autologous donor-patients. A previously unobserved phenomenon was that surgeons tended to transfuse less blood to patients who had autologous blood available, rarely exceeding the number donated, although this varied from one to three units for similar surgery. Only eight of the 103 patients intentionally received a transfusion with homologous blood in addition to their autologously donated blood. Patients, their physicians, and the blood bank can all benefit substantially from such a program.
对参与社区血库资助的自体输血项目的103名患者的临床记录进行审查，证实了自体血的安全性以及这种以社区为中心的项目的可行性。自体供血患者中没有发生输血反应、发病率增加或肝炎报告。一个以前未观察到的现象是，外科医生往往会给有自体血可用的患者少输血，很少超过所捐献的数量，尽管类似手术的输血量在1至3个单位之间有所不同。103名患者中只有8人在自体献血之外还特意接受了异体输血。患者、他们的医生和血库都能从这样一个项目中大幅受益。
